Alert detail
LCD L36125: MolDX: Breast Cancer Assay: Prosigna® — Palmetto GBA
What changed
Prosigna® breast cancer genomic assay coverage—MolDX rules apply.
Who’s affected: Oncology billing teams · Effective: April 22, 2021
Primary source: View the official CMS/MAC document ↗
Get the action steps and full analysis
This change affects 7 billing codes.
The full analysis, the revision comparison and the as-of-date version of this policy are what a partner packet carries. The source document above is free and always will be.